Authors:
Lazzarino, M
Corso, A
Barbarano, L
Alessandrino, E
Cairoli, R
Pinotti, G
Ucci, G
Uziel, L
Rodeghiero, F
Fava, S
Ferrari, D
Fiumano, M
Frigerio, G
Isa, L
Luraschi, A
Montanara, S
Morandi, S
Perego, D
Santagostino, A
Savare, M
Vismara, A
Morra, E
Citation: M. Lazzarino et al., DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma, BONE MAR TR, 28(9), 2001, pp. 835-839
Authors:
Bassan, R
Rohatiner, AZS
Lerede, T
Carter, M
Di Bona, E
Pogliani, E
Rossi, G
Fabris, P
Morandi, S
Lambertenghi-Deliliers, G
Casula, P
Vespignani, M
Lister, TA
Barbui, T
Citation: R. Bassan et al., Early application of anthracyclines in adult acute lymphoblastic leukemia (ALL), HEMAT BLOOD, 40, 2001, pp. 402-413
Authors:
Bassan, R
Rambaldi, A
Pogliani, E
Rossi, G
Fabris, P
Morandi, S
Casula, P
Lambertenghi-Deliliers, G
Vespignani, M
Lerede, T
Personeni, A
Bellavita, P
Barbui, T
Citation: R. Bassan et al., Preliminary results of a risk-oriented program for B-lineage adult acute lymphoblastic leukemia (ALL): The collaborative Italian study 08/96, HEMAT BLOOD, 40, 2001, pp. 419-425
Authors:
Bassan, R
Rohatiner, AZ
Di Bona, E
Lerede, T
Carter, M
Rambaldi, A
Pogliani, E
Rossi, G
Fabris, P
Morandi, S
Lambertenghi-Deliliers, G
Lister, TA
Barbui, T
Citation: R. Bassan et al., Prognostic factors in Philadelphia plus BCR-ABL plus acute lymphoblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 426-431
Authors:
Bassan, R
Pogliani, E
Lerede, J
Fabris, P
Rossi, G
Morandi, S
Casula, P
Lambertenchi-Deliliers, G
Vespignani, M
Izzi, T
Coser, P
Corneo, G
Barbui, T
Citation: R. Bassan et al., Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractorydisease in T-lineage but not B-lineage acute lymphoblastic leukemia: firstresults from a phase II clinical study, HAEMATOLOG, 84(12), 1999, pp. 1088-1093